Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_927_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
31 Мб
Скачать
COMPLICATIONS 431

MINIMIZING RISK ASSOCIATED WITH IMMUNOSUPPRESSION

Steroids
Chronic steroid use resulting from rheumatic, pulmonary, or inam­matory bowel diseases is particularly challenging. In addition to sev­eral adverse eects, including osteoporosis, diabetes, and glaucoma, high doses of steroids have detrimental eects on tissue integrity. A meta-analysis of seven studies on postoperative complications and steroid use in persons with inammatory bowel disease (IBD) included more than 1500 patients and demonstrated an OR of 1.41 (95% CI, 1.08 to 1.87) for all postoperative complications, including wound breakdown, anastomotic leak, and infectious complications in the steroid group. In a German study of more than 650 CD anas­tomoses, the only factor signicantly associated with overall anas­tomotic complication rate on multivariate analysis was steroid use. us, ideally, steroids should be tapered preoperatively if possible. When tapering is not possible, a diverting stoma should be consid­ered to protect the downstream anastomosis. Patients taking steroids on a long-term basis may require perioperative stress dosages that are tapered postoperatively to their baseline levels within 3 to 5 days. However, recent studies have suggested that perioperative stress ste­roids are overused. To determine how readily steroids can be totally discontinued in the chronic user, intrinsic adrenal function can be estimated using a cosyntropin test. is test should be considered especially in septic patients who use steroids, who require maximiza­tion of their immune function to ght infection. 
Diabetes
Diabetes mellitus, both insulin-dependent and non–insulin­dependent types, is a risk factor for postoperative complications, particularly surgical site infections. e risk of infection rises with increasing glucose levels. e American Diabetes Association rec­ommends maintaining blood glucose levels below 200 mg/dL to minimize surgical site infections, which may require the institution of a perioperative insulin sliding scale for both insulin-dependent and non–insulin-dependent diabetics who are fasting periopera­tively and unable to take their oral hypoglycemics. e target glu­cose level for patients on an insulin sliding scale is between 140 and 180 mg/dL as recommended by the American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control. Additionally, glycosylated hemoglobin (HbA1c), which is indicative of long-term (90 to 120 day) glycemic control, has been thoroughly studied as a predictor of poor outcomes in orthopedic, bariatric, and plastic sur­gery but is less studied in colorectal surgery. Gustafsson’s study of 120 diabetic patients undergoing colorectal surgery demonstrated that higher preoperative HbA1c levels correlated with higher post­operative blood glucose levels and increased complications. e HbA1c level should be measured during the preoperative visit for elective cases. If the level is high, surgery should be postponed until better control is achieved. Additionally, the risks associated with secondary organ eects of the diabetes should be evaluated. ese risks include the possibility of silent myocardial disease, PVD, and chronic renal failure. 
Chemoradiotherapy
Preoperative or neoadjuvant chemotherapy and/or radiotherapy aims to decrease tumor size in persons with colorectal cancer to allow for a more complete surgical resection and sphincter-sparing surgery in persons with tumors located close to the sphincters. Although there is an increased risk of long-term adverse eects such as impaired
bowel function, incontinence, sexual dysfunction, and pelvic frac­tures in patients with rectal cancer who have undergone preoperative irradiation, most studies show no dierence in rates of intraopera­tive or immediately postoperative complications. However, more frequent acute hospital admissions for bowel obstruction, abdominal pain, nausea, and infections (of varying severity) both during radia­tion therapy and within 6 months aer completion of treatment, as well as increased rates of venous thromboembolism, bowel obstruc­tion, and stula formation, have been demonstrated.
Chemotherapy impairs immunity and increases the risk of periop­erative infection of any type, including overwhelming systemic sep­sis. Collaboration with the treating oncologist is recommended, and colorectal surgery should be delayed until sucient time has passed for the recovery of the immune system, which is commonly believed to be at least 6 weeks. When emergency surgery is performed for a patient undergoing chemotherapy, the white blood cell count should be carefully monitored, intravenous antibiotics should be adminis­tered, and a low suspicion for infection should be maintained. Neu­tropenia is an indication to delay elective procedures. An absolute neutrophil level less than 1000/μL is indicative of neutropenia, with levels less than 500/μL indicating severe, life-threatening neutrope­nia. Several case studies of neutropenic patients who have required emergency abdominal surgery have demonstrated a major postop­erative complication rate of 50% and a 30-day postoperative mortal­ity rate of more than 30%. ese patients require broad-spectrum antibiotic coverage, with the consideration of antifungal treatment. If surgery cannot be avoided in the neutropenic patient, frequent moni­toring for clinical signs of infection is key because white blood cell elevation cannot be relied upon to reect infection. All indwelling catheters should be removed as soon as possible, and close collabora­tion with colleagues in oncology/hematology is recommended. Few guidelines address perioperative administration of granulocyte col­ony-stimulating factor (G-CSF) in the neutropenic surgical patient. G-CSF stimulates the production of neutrophils from progenitor cells and is recommended in patients at high risk for sepsis, including those with open wounds. Intravenous administration of G-CSF can cause headaches, rash, nausea, and diarrhea.
Bevacizumab is an antiangiogenic drug used in the treatment of metastatic colorectal cancer and in some breast, lung, and ovarian cancers and glioblastomas. However, use of bevacizumab has been associated with multiple postoperative complications, including bleeding, wound dehiscence, and poor wound healing. In colorec­tal surgery in particular it has been associated with increased risk of pelvic sepsis and colonic anastomotic leaks. us a defunctioning stoma should be considered, particularly if surgery is not able to be postponed beyond the recommended 6 weeks aer the last dose of the drug. Ideally, the drug can be restarted 28 days aer surgery to reduce the likelihood of late surgical morbidity, particularly in rela­tion to wound healing.
Chronic radiation enteritis is a distinct entity that most commonly presents between 18 months and 5 years aer radiation treatment but also can be present several years aer the last dose of radiation. It is most commonly seen aer treatment for gynecologic, prostate, and rectal tumors. Approximately a third of these patients require surgery for subsequent enteritis, with this probability correlating with dos­age. Patients who have been exposed to pelvic radiation are at risk for late strictures and rectal or vaginal bleeding. e risk of anastomotic leak aer resection of the chronically damaged tissue is unclear, with some studies nding no dierence between irradiated and nonirradi­ated patients and others nding anastomotic complications only in irradiated patients. Acute radiation injury usually causes bowel wall edema and can precipitate obstruction. is edema usually resolves when radiation stops, and bowel rest and nasogastric decompression are started. Preoperative preparation oen involves oral antibiotics to treat bacterial overgrowth, even in cases of small bowel strictures. It is important to recognize that the pathophysiology of radiation enteri­tis relates to small vessel obliteration with resultant tissue ischemia, and thus surgery involves meticulous technique. Stricturoplasty is
ColoreCtal Surgery in the high-riSk Patient432
not advised, but rather resection and anastomosis with care taken to anastomose only healthy tissue. e use of the omentum to wrap or separate one or more anastomoses from adjacent organs to avoid a stula is recommended, and creation of a temporary protecting stoma is wise. 

MINIMIZING RISK ASSOCIATED WITH MALNUTRITION

Signicant nutritional compromise can worsen perioperative mor­bidity. Malnutrition is a potentially signicant problem in two par­ticular classes of patients undergoing colorectal surgery: those with colorectal cancer and those with IBD. Patients with colorectal can­cer, particularly those with late stage, metastatic disease, can suer from the cachexia of malignancy and compromised intake due to partial obstruction or dysmotility. Patients with CD oen experi­ence malnutrition because of semi-obstructing inamed segments of diseased bowel, as well as previous multiple small bowel resections leading to a short gut. Additionally, these patients experience nutri­ent loss resulting from frequent diarrhea, high-output ileostomies, and losses through enteric stulae. Factors used to assess nutritional state include serum albumin, transferrin and prealbumin, percentage of total body weight lost, and triceps skinfold thickness (as a mea­sure of fat stores). Such factors are included in the Prognostic Nutri­tional Index, a tool designed to predict complications, mortality, and postoperative sepsis (Table 81-6). Generally, an albumin level below
3.0 g/dL and a serum transferrin level less than 170 mg/dL indicate moderately severe malnutrition and an increased likelihood of poor outcomes. Buzby etal developed a formula using Prognostic Nutri­tional Index parameters to calculate the linear risk of postoperative morbidity or mortality aer gastrointestinal surgery (see Table81-6). is index and formula are nonspecic and predict complications in general, not serious versus nonserious complications.
Patient optimization with several days of total parenteral nutrition
(TPN) before major colonic surgery is warranted in malnourished
TABLE 81-6: Prognostic Nutritional Index
Parameters and Increased Risk of Complications
Overall Increased Risk
Poor
Parameter
Delayed hypersensi-
tivity in response
Prognosticator
>5 mm induration
response to 0.1 mL of 1of 3 subcutaneously administered antigens (mumps, Candida albicans, and streptokinase/ Streptodornase)
Albumin <3.0 g/dL 2.5×
Transferrin level <220 mg/dL
Buzby etal developed a formula using the Prognostic Nutritional Index (PNI) parameters to calculate the risk of a complication occurring. Risk (percent) = 158 − 16 (serum albumin g/100 mL) −0.78 (Triceps skinfold, mm) − 0.20 (serum transferrin g/100 mL) − 5.8 (delayed hypersensitivity, 0 = none, 1 = induration <5 mm in response to 0.1 mL of 1 of 3 subcutane­ously administered antigens mumps, Candida albicans, and streptokinase/ Streptodornase and 2 = >5 mm induration). Low risk is suggested by a PNI score of <40. Intermediate and high risk are suggested by scores of 40-49 and ≥50, respectively.
of a Postoperative Complication
2.5×
patients. However, this optimization is not possible in emergen­cies, in which case postoperative nutritional supplementation must be administered. When treating malnutrition, the underlying cause must be ascertained (e.g., lack of caloric intake, lack of absorption, and increased losses/catabolism). Enteral feeding with a nasogastric tube and high-protein and high-calorie feedings are best in cases in which the patient is not eating but has an intact and patent gastroin­testinal tract. is option should be kept in mind especially during surgery, because surgical placement of a gastrointestinal or gastroje­junal feeding tube can improve and simplify postoperative manage­ment immeasurably, especially in the critically ill patient. Similarly, malnutrition resulting from an obstructing cancer may be improved by the creation of a diverting stoma prior to resection so the patient can resume an oral diet.
TPN is best used in cases of short gut or other intrinsic intestinal disease. When it is known that a patient will be without a regular oral diet for more than 5 to 7 days, TPN supplemented with low­residue oral supplements is optimal to maintain nutrition and the integrity and defensive barrier function of the intestinal epithelium. When nutritional requirements are excessive because of disease such as medically unresponsive ulcerative colitis or a CD phlegmon, TPN will not replace the ongoing loss of blood, albumin, and other pro­teins. In such cases, prompt surgical resection is required or further nutritional deterioration will occur. 

MINIMIZING RISK ASSOCIATED WITH HEPATIC DISEASE

Hepatic failure is a signicant risk factor for colorectal surgery. Mor­tality risk is commonly assessed using the Child-Pugh Classication. Each parameter (serum bilirubin, serum albumin, international nor­malized ratio, ascites, and hepatic encephalopathy) is given a number from 1 to 3 based on severity. e sum of these numbers correlates with approximate mortality rate. Modied bilirubin scores have been determined for patients with the primary sclerosing cholangitis found in association with IBD.
e Model for End-Stage Liver Disease score uses some of the same parameters as the Child-Pugh Classication to create a formula to predict survival (Model for End-Stage Liver Disease = 3.78[Ln serum bilirubin (mg/dL)] + 11.2[Ln international normalized ratio] + 9.57[Ln serum creatinine (mg/dL)] + 6.43) (Table 81-7). is scor- ing system was developed for use in patients undergoing transjugular intrahepatic portosystemic shunt procedures to predict the odds of death within 3 months of surgery. It is now more commonly used to determine prognosis in patients awaiting liver transplantation.
TABLE 81-7: Model for End-Stage Liver Disease
Scoring Systems for Hepatic Disease Values and Risk of 3-Month Overall Mortality
MELD Score 3-Month Mortality (%)
≥40 71
30-39 53
20-29 20
10-19 6
≤9 2
e Model for End-Stage Liver Disease (MELD) score is not a scoring system to determine risk of surgical morbidity or mortality. However, it is used in surgical situations to give a general assessment of a patient’s liver status. MELD = 3.78[Ln serum bilirubin (mg/dL)] + 11.2[Ln international normal­ized ratio] + 9.57[Ln serum creatinine (mg/dL)] + 6.43).
COMPLICATIONS 433
Although the calculated survival rate is independent of surgery and thus does not reect surgical morbidity or mortality, it can be used in surgical situations to give a general impression of a patient’s liver status.
e perioperative care of the cirrhotic patient is a big under­taking requiring careful management of volume, coagulation, and nutritional status. Performing a colectomy with anastomosis in such patients can result in peritoneal sepsis secondary to contaminated ascites, whereas the creation of a stoma can also lead to a leak of ascites, or peristomal varices. To avoid an ascites leaking around a stoma, a Jackson-Pratt (JP) drain should be placed intraoperatively at a remote site that subsequently can be easily bagged aer removal (aer the stoma has healed). Colorectal surgery in the severely cir­rhotic patient should be limited to treating critical life-threatening or malignant disease. 

MINIMIZING RISK ASSOCIATED WITH RENAL DISEASE

Impaired renal function is an independent risk factor for adverse postoperative cardiovascular outcomes, including stroke, myocardial infarction, and the worsening of heart failure. Such impaired renal function can be worsened by the use of contrast material for radio­logic investigations and hypotension resulting from perioperative blood or uid loss. Renal function is primarily assessed using serum creatinine measurements. Careful uid management and the avoid­ance of nephrotoxic analgesics and antibiotics (intravenous contrast material, nonsteroidal antiinammatory drugs, aminoglycoside anti­biotics, and angiotensin-converting enzyme inhibitors) are key in these patients. 

MINIMIZING RISK IN MORBIDLY OBESE PATIENTS

Obesity rates are increasing worldwide. e physiologic state of being overweight or obese has been suggested to be a low-grade inam­matory state and has been associated with the development of auto­immune diseases, a more severe phenotype in IBD, and increased postoperative complications aer colorectal and other surgery. Perioperative morbidities directly correlated with body mass index include cardiac complications, venous thromboembolism, intra­abdominal collections, wound infections, the need for perioperative blood transfusions, anastomotic leak, and death. Obese patients also have longer operative times, which are associated with an increased risk of pulmonary complications. Higher intra-abdominal pressures during pneumoperitoneum for laparoscopy have been observed in morbidly obese patients, leading to negative eects on venous stasis,
portal venous blood ow, airway pressure, cardiac function, uri­nary output, and respiratory compliance. Additionally, in an inter­esting Korean study of 171 resectable colorectal cancers in patients with high visceral/subcutaneous fat ratios, these patients had a sig­nicantly lower cumulative disease-free survival rate compared with patients who had a low ratio. Because of these increased risks, venous thromboembolism prophylaxis including early mobilization, chest physiotherapy, and careful attention to wound care, including lapa­roscopic techniques to decrease wound size, should be undertaken in this cohort.

S u g g e S t e d R e a d i n g

Benoist S, Panis Y, Alves A, Valleur P. Impact of obesity on surgical outcomes
aer colorectal resection. Am J Surg. 2000;179(4):275–281.
Bilimoria KY, Liu Y, Paruch JL, etal. Development and evaluation of the univer-
sal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013;217(5):833–842.
Gustafsson UO, orell A, Soop M, et al. Haemoglobin A1c as a predictor
of postoperative hyperglycaemia and complications aer major colorectal surgery. Br J Surg. 2009;96(11):1358–1364.
Koltun WA, McKenna KJ, Rung G. Awake epidural anesthesia is eective and
safe in the high-risk colectomy patient. Dis Colon Rectum. 1994;37(12): 1236–1241.
Kouroukis CT, Chia S, Verma S, etal. Canadian supportive care recommen-
dations for the management of neutropenia in patients with cancer. Curr Oncol. 2008;15(1):9–23.
Louwers L, Schnickel G, Rubinfeld I. Use of a simplied frailty index to pre-
dict Clavien 4 complications and mortality aer hepatectomy: analysis of the National Surgical Quality Improvement Project database. Am J Surg. 2016;211(6):1071–1076.
Malinchoc M, Kamath PS, Gordon FD, etal. A model to predict poor survival
in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864–871.
Mullen JL, Gertner MH, Buzby GP, etal. Implications of malnutrition in the
surgical patient. Arch Surg. 1979;114(2):121–125.
Ondrula DP, Nelson RL, Prasad ML, etal. Multifactorial index of preoperative
risk factors in colon resections. Dis Colon Rectum. 1992;35(2):117–122.
Poldermans D, Bax JJ, Boersma E, etal. Guidelines for pre-operative cardiac
risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the Euro­pean Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol. 2010;27(2):92–137.
Sehgal R, Berg A, Figueroa R, etal. Risk factors for surgical site infections aer
colorectal resection in diabetic patients. J Am Coll Surg. 2011;212(1):29–34.
Tekk is PP, Prytherch DR, Kocher HM, etal. Development of a dedicated risk-
adjustment scoring system for colorectal surgery (colorectal POSSUM). Br J Surg. 2004;91(9):1174–1182.
Zaghiyan K, Melmed GY, Berel D, etal. A prospective, randomized, nonin-
feriority trial of steroid dosing aer major colorectal surgery. Ann Surg. 2014;259(1):32–37.

R P S
Jon Worsey and Victor Fazio

INTRODUCTION

Reoperative pelvic surgery is one of the most dicult challenges a colon and rectal surgeon can face. Anatomic, postsurgical, and dis­ease-specic factors combine to present unique challenges with sig­nicant potential for major morbidity and even mortality. is is not the occasion for hubris or poor judgment. However, with a thorough understanding of normal and postsurgical anatomy, experience in operating in the pelvis, appropriate planning, sound judgment, and a methodical team approach, a successful outcome may be achieved. 

ANATOMIC FACTORS

e pelvis is a bony cavity with limited visibility and access. e limi­tations are due to multiple factors: its bony walls, its angulation, the narrowness and depth of the male pelvis, and patient obesity. e pelvis contains complex gastrointestinal, urologic, gynecologic, and neurovascular structures that are in danger during pelvic surgery, and especially during reoperative pelvic surgery. Particularly vulner­able are the ureters, the presacral veins, and the pelvic nerves.
The Ureters
e distal ureter is a retroperitoneal structure that enters the pelvis by passing over the bifurcation of the common iliac artery. It then runs along the lateral pelvic sidewall beneath the investing parietal pelvic fascia before turning upward and medially to enter the trigone of the bladder. 
into the pelvis. Pelvic parasympathetic nerves join them to form the pelvic autonomic nerve plexus. Nerves from this plexus pass ante­riorly and medially to the bladder, urinary sphincter, rectum, and genital organs, separated from the anterior rectum by Denonvilliers fascia, which may be seen as a discrete white layer in some cases. 

POSTOPERATIVE CHANGES IN THE PELVIS

Pelvic surgery can cause a variety of changes to pelvic anatomy. Small bowel may fall into the pelvis and become adherent, sometimes in a dense manner, and must be mobilized before any pelvic work can begin. A previously mobilized rectum sinks deep into the pelvis and oen will become xed to its surroundings and dicult to mobilize. A short rectal stump may retract down to the pelvic oor and not be apparent at all. Similarly, a mobilized ureter can be in a mark­edly ectopic location, oen migrating medially and being fused to intestine or its mesentery, where it is at risk of injury. e usually well-dened fascial planes are oen obliterated and may be very dif­cult to delineate and follow. is situation is of particular relevance with regard to the autonomic nerves and presacral veins, which nor­mally sit behind the endopelvic or presacral fascia. Disturbance of these fascial planes exposes the nerves and veins to damage. Finally, disease or treatment-specic factors such as sepsis, recurrent cancer, irradiation, and obstruction all can add signicant diculty to a sur­gical approach.
Approach to Reoperative Pelvic Surgery
Presacral Veins
e presacral veins run beneath the thickened parietal pelvic fascia that covers the sacrum and coccyx, which is oen referred to as the presacral fascia. ese veins form a plexus over the lower part of the sacrum and connect with the large basivertebral veins. ere are no valves in the connecting veins to prevent or minimize back bleeding, and the connecting veins themselves are fused to the sacral foramina. ey cannot contract. Presacral venous bleeding is usually low pres­sure but resists attempts at control by suture or cautery. 
Pelvic Nerves
e sympathetic nerves originate from the hypogastric plexus above the bifurcation of the aorta and coalesce around the inferior mes­enteric artery to form the discrete hypogastric nerves. ese nerves then cross the pelvic brim behind the presacral fascia to pass laterally
434
Strategy
Planning reoperative pelvic surgery demands a realistic analysis of the benets to be gained and the risks to be run. is analysis is an important part of any surgery but assumes critical importance for a procedure in which the risks are unusually high. Patients must understand the risks and have realistic expectations. e option of performing no surgery at all must be discussed. 
Preoperative Planning
Timing
Appropriate timing of a repeat operation may reduce the diculty and potential complications attributable to adhesions. Early reopera­tive pelvic surgery is usually an emergency, and thus all eorts are directed to dealing with the urgent problem. Even for emergency sur­gery, there is a window of about 10 to 14 days before postoperative
COMPLICATIONS 435
adhesions reach their most dense and dangerous. Aer this period, there is a signicant risk of iatrogenic injury to the bowel because the inammatory nature of the adhesions at this point in their develop­ment predisposes to bowel injury. It is preferable to wait at least 3 months before performing a repeat operation. If something must be done to divert stool to manage sepsis, approaches such as percutane­ous abscess drainage, proximal fecal diversion, or parenteral nutri­tion can buy time. Factors that may make adhesions worse include sepsis, ischemia, and irradiation. If these factors are present, a repeat operation should be delayed at least 6 months. 
Patient Preparation
e patient’s nutritional state should be optimal, and comorbidities should be treated. Long operations, underlying malignancy, and big incisions increase the risk for postoperative atelectasis and pneu­monia, as well as deep venous thrombosis. Aggressive deep venous thrombosis prophylaxis may sometimes require caval lter place­ment. Mechanical bowel preparation is a matter of preference, and many surgeons now believe it is not routine or mandatory. 
Define the Anatomy
e preoperative strategy may be aided by imaging and endoscopy if the exact details of the prior operation are unclear or unreliable. Knowing the length of a rectal stump or whether there may be an unexpected “stump blowout” or abscess is very helpful. Computed tomography (CT) scanning and magnetic resonance imaging (MRI) also may provide a road map of pelvic anatomy when a signicant interval change has occurred as a result of a treated abscess or anas­tomotic leak.
In the case of malignant disease, it is essential to exclude unre­sectable pelvic cancer or distant metastatic disease that would pre­clude a curative procedure. Whereas clinical features such as nerve root or sciatic pain suggest unresectability, determining resectability of malignant pelvic disease on clinical-pathologic grounds alone can be unreliable. CT and/or MRI can identify features associated with either a signicantly lower chance of resectability (pelvic side wall involvement and ureteric obstruction) or features more oen ame­nable to curative resections (anterior pelvic or isolated anastomotic recurrence). Positron emission tomographic–CT scanning is also routinely performed in the case of malignant pelvic recurrence. In the absence of sepsis it is usually sensitive and specic for recurrences greater than 1 cm. Identication of liver or lung metastases that are not amenable to resection also may discourage a highly morbid pal­liative pelvic operation. Positron emission tomographic-CT scanning is also useful in distinguishing postoperative changes from locally recurrent malignant disease in the pelvis. 
Anticipate and Prepare for a Difficult Case
Blood should be cross-matched and the availability of clotting agents, such as platelets, fresh frozen plasma, and cryoprecipitate should be conrmed in case massive transfusion is required. Many institutions now have protocols for massive transfusion in which specic addi­tional blood products and clotting factors are given routinely aer a specic amount of transfused blood.
Having the right operation at the right time of day by the right surgical team is well worth the investment. One should start early, have experienced help, and forewarn anesthesiologists and other sub­specialists who may be needed, such as urologists or gynecologists. Anesthesiologists must be given time to place appropriate lines for rapid volume administration and monitoring. 
can be predicted preoperatively by examining factors such as age, anal tone/squeeze, extent of intestinal resection, prior irradiation, and prior pelvic sepsis. Proper informed consent should take these factors into consideration, and when appropriate, a permanent stoma should be part of the discussion. 
Intraoperative Conduct
Patient Positioning
Careful positioning and padding are essential to avoid injury due to pressure or poor positioning during a long operation. A bean bag or a foam pad are good choices and help prevent the patient from slip­ping down the table if a steep Trendelenburg position is applied. Both arms should be tucked securely at the patient’s side even if the patient is obese so as not to limit the room required to obtain adequate access. e legs are placed in carefully positioned and padded Allen or yel­low n stirrups. e hips are not overexed, which would interfere with a self-retaining retractor placed in the most distal aspect of the wound. Neither are the hips overextended, in the interest of avoiding stretch injury to nerves in the anterior compartment of the thigh. e patient is prepared from the xiphoid to the perineum and draped so that access to the perineum can be obtained without contaminating the abdominal eld. 
Optimizing Visibility and Exposure
A long midline incision is the standard approach, with the distal end carried down to the pubis and the proximal incision as far cephalad as needed. Safe entry to the abdomen may need to be above the umbi­licus, away from prior dense adhesions or stulas. Enterocutaneous stulas are le in place until the bowel around them is fully mobilized to minimize contamination and avoid injury to uninvolved bowel. A self-retaining retractor is used, although a variety of retraction systems are available. A bladder blade can be attached to the self­retaining retractor and is tightened up against the pubic bone. A large chromic suture can be placed in the dome of the uterus and then tied around the bladder blade to pull the uterus up out of the pelvis. Once the small bowel has been brought up out of the pelvis, placing the patient in the Trendelenburg position will help keep the pelvic eld clear, or it may be packed away using a “C” arm retractor or a broad malleable retractor bent into a “U” shape.
Excellent overhead lighting is essential and can be supplemented by a lightweight ber-optic headlight, as well as lighted retractors. A number of specialized pelvic retractors are available that are long and curved to t the shape of the pelvis and can be attached to a ber-optic light source. e lighted Deaver retractor (Fig. 82-1) has a relatively shallow curve and is a short, broad instrument that is ideal for the early part of the posterior rectal dissection. Deeper in the pelvis we use the deep pelvic retractor, which comes with distal blade widths from 25 to 50 mm and has two styles of handle, one named aer the senior author who helped develop it (Fig. 82-2). It is especially useful in liing the rectum upward and forward with some
Functional Considerations
Although avoidance of a permanent stoma is a laudable goal, the like­lihood of good function, continence, and patient satisfaction oen
FIGURE 82-1 A lighted Deaver retractor with handle (ESI/FTT Medi-
cal Inc., Rochester, N.Y.).
ReopeRative pelvic SuRgeRy436
degree of force to accentuate the correct plane of dissection behind the rectum. In addition, it can be used to retract the bladder and pros­tate or vagina forward to assist with anterior visualization and dissec­tion. An alternative is the St. Mark retractor, which also comes in a curved and lighted model (Fig. 82-3). 
Access to the Pelvis
Once the abdomen has been entered, the small bowel needs to be deliv­ered up out of the pelvis where it is oen fused to the vagina, rectal stump, levators, or anterior sacrum. e aerent and eerent loops descending into the pelvis need to be identied and gently retracted with the nondominant hand to try to visualize the apex of the loop. Sharp dissection is performed close to the bowel wall, and enterotomies or myotomies may be unavoidable or incidental, necessitating repair or resection once mobilized out of the pelvis and separated. Dissection of the densest adhesions may be facilitated by inltrating the fused area with saline solution using a small-gauge needle (hydrodissection). is maneuver preferentially expands the correct plane for dissection and reduces the likelihood of bowel injury. It also may be of value in nd­ing a plane between the vagina and the previously mobilized rectum.
If no progress is being made in exposing or dening the pelvic
anatomy, one must decide early if the potential for harm is becoming
greater than the potential for good. If so, temporizing measures such as drain placement or proximal diversion are options, and further waiting or referral to surgeons with more experience should be con­sidered. ink carefully before “crossing the Rubicon” by dividing the blood supply or irreparably damaging bowel, or getting into bleeding in an area where it cannot be controlled. 
Identification of Specific Pelvic Structures
Ureter
Early identication of the ureters on both sides of the pelvis in which a repeat operation is being performed is the key to avoiding injury. In a densely scarred pelvis, the ureters are found proximally and traced to the pelvis. ey may be marked by loosely placed encir­cling ligatures and are constantly referred to during conduction of the dissection. Ureteric blood supply is segmental, and thus excessive mobilization may lead to ischemia.
Preoperative placement of ureteric stents increases cost and time but allows ureteric damage to be recognized. If a stent is not or can­not be placed, the intravenous administration of indigo carmine (5 mL) will turn the urine blue and can help detect an occult injury with leaking urine.
A urine leak presents postoperatively as excessive output of a pelvic drain. e uid has a very high creatinine level. If there is no drain, presentation may be more subtle with a slight rise in serum creatinine, an ileus, and ultimately drainage of urine through the wound. Some ureteric injuries present late with a stricture and vary­ing degrees of hydronephrosis and impaired renal function. e most common sites of injury are at the pelvic brim and distally. 
FIGURE 82-2 A lighted deep pelvic retractor (ESI/FTT Medical Inc.,
Rochester, N.Y.); the “Fazio” handle is on the left, and the standard handle is on the right.
FIGURE 82-3 A lighted St. Mark retractor with lip and angled blade
(ESI/FTT Medical Inc., Rochester, N.Y.).
Bladder
If the previous abdominal incision was taken down to the pubis for maximal exposure, the bladder may be densely adherent to the mid­line fascia in the lower part of the wound where it may be inadver­tently injured. e combination of proctectomy and pelvic radiation causes a tight, restrictive, crescent-shaped band in the deep pelvis corresponding to a brous bladder base, which will limit exposure and access to the low pelvic and pelvic oor. is can be managed by making several supercial cautery incisions in the brous arc and then stretching the narrow entrance. 
Rectal Stump
If prior pelvic dissection and rectal mobilization has been minimal, the rectal stump usually is not dicult to nd. However, if the rec­tum was initially divided at or below the sacral promontory, the stump may retract and the divided end may be adherent to the presacral fascia, the great vessels, or the ureters. It is sometimes possible to begin the rectal dissection more distally and laterally in “virgin tissue” and to start the development of the plane behind the mesorectum here. Once the peritoneum has been incised, this is facilitated by retracting the rectum medially using the lighted Deaver retractor and then using electrocautery to follow the meso­rectum posteriorly to the presacral space. e proximal part of the rectal stump is then mobilized by sharp division of the adhesions, obscuring the plane between the posterior mesorectum and the pre­sacral fascia. Potentially fused ureters, sympathetic trunks, or ves­sels are dissected and freed.
Placement of a large bougie or proctoscope in the rectum can identify a short, nearly invisible rectal stump. Bimanual palpation, with a hand in the pelvis and a nger transanally, is a useful technique not only to identify the rectum but also to accurately assess the level of the dissection in relation to the sphincters. Before any anastomo­sis is attempted to a defunctionalized rectum, an occult stricture or inspissated mucus must be excluded, which can be determined either preoperatively or intraoperatively. 
COMPLICATIONS 437
Vagina
In repeat operations, the vagina should always be prepared with povidone-iodine in case it is inadvertently entered. An obturator or a bougie may be extremely helpful in the identication and preven­tion of a vaginal injury. Occasionally, bimanual palpation with one nger in the rectum and one in the vagina facilitates the separation of the most distal aspects of the rectum and vagina. If the vagina is injured, a layered repair is appropriate. Adequate mobilization from the rectum and care when both passing and closing a stapling device are keys to avoiding incorporation of the vagina in the ante­rior part of stapler. Aer prior proctectomy without reanastomo­sis, the vagina may adhere to the sacrum. It must be mobilized if reconstruction with a pouch is to be achieved. is procedure is dicult because bleeding from the presacral plexus may occur if the dissection is too deep, and entry into the vagina may occur if it is too shallow. 
Autonomic Nerves
Loss of fascial planes aer prior surgery places the sympathetic hypo­gastric nerves at risk at the pelvic brim. Damage to the nerves can cause retrograde ejaculation in the male and vaginal dryness in the female. Both sympathetic and parasympathetic (nervi erigentes) nerves are at risk anterior to the rectum if Denonvilliers fascia is inadvertently or necessarily breached. Damage here can cause male impotence and diculty with urination. 
Control of Bleeding
e common sites at which pelvic bleeding is encountered are listed in Box 82-1.
If the point of signicant bleeding cannot be identied quickly, an index nger should be used to apply pressure. Should this pressure fail to stop the bleeding, one should place packs and wait a minute or so. Good lighting, adequate suction, and good exposure are then the keys to identifying and addressing the source of the bleeding. Inform the anesthesiologist of the problem, and allow him or her to catch up with blood loss and send for more blood. en gently tease out the packs until the bleeding site is seen. A sponge or small cotton pledget on an instrument should be used to control the bleeding, thus allow­ing room to perform measures to stop the bleeding.
Presacral bleeding may be cauterized using a high coagulation current, but sometimes this maneuver damages adjacent presacral veins and worsens the bleeding. Suturing with a ¾-circle needle (e.g., 2-0 Vicryl or Prolene on a UR6 needle) is reasonable if the bleeding is localized and sucient intact fascia exists on either side to provide tamponade. If intact fascia is insucient, a sterile thumbtack can be driven into the sacral foramen with or without some Surgicel secured beneath it. e thumbtack is best driven home using the at part of a heavy pair of scissors or a specically designed applier. Should the area be too large for a single tack, a roll of Surgicel or a 1-cm cube of rectus muscle may be sewn over the bleeding point again using a stout ¾-circle needle. If this maneuver does not work, then apply Surgicel to the bleeding area, pack it, and halt the operation. Aer 48 hours, remove the packs and complete the procedure. Recurrent bleeding aer 48 hours is rare.
BOX 82-1: Common Sites/Causes of Pelvic Bleeding
• Presacralandlateralsacralveins,whenthepresacralfasciais
inadvertently or deliberately incised
• Internaliliacvein • Rectovaginal,retroprostatic,andparavesicalveinswithante-
rior/anterolateral dissection
• Sacralorpresacralartery • Anyofthearterialstructuresinthepelvis
e most important consideration is performing packing early before the patient experiences massive blood loss and the vicious downward spiral of coagulopathy and hypothermia has begun. Packs should be rmly placed at the site of bleeding and not roughly stued into the pelvis so as to cause shearing of small veins and compound­ing of the problem. If a pelvic anastomosis was to be created and the packs need to be retained for 24 to 48 hours, the anastomosis should be delayed until the packs are removed, because a tightly packed pel­vis may compromise the blood supply of the proximal bowel and put tension on the newly created anastomosis.
Direct injuries to a major vein usually can be managed with repair, oversewing, or ligation above and below the injury. Arterial injuries also may be treated by ligation or oversewing if bleeding is from small distal branches. A single internal iliac artery usually can be ligated without untoward eects. Injury to the external iliac artery must be repaired. ese injuries warrant a vascular surgeon’s assistance. 
Drainage
We routinely place a drain in the pelvis that has undergone a repeat operation. If bleeding has been completely controlled, a single Jackson-Pratt or Blake suction drain will suce. However, if oozing persists or if fecal contamination has occurred, then sump drains are used and brought out through a separate stab incision rather than through the wound. ese drains can be irrigated with normal saline solution for 48 hours and removed a day or two aer that. e omen­tum is routinely mobilized as a pedicle gra o the le side of the transverse colon and brought down the le paracolic gutter to ll dead space in the pelvis or to wrap around and isolate an anastomo­sis. Keeping the small bowel out of the pelvis may help prevent future obstructions. One or two sutures are used to hold the omentum in the pelvis or to incorporate it into the perineal wound closure in the case of abdominoperineal resection. Perineal drains are rarely used. 

SPECIFIC CLINICAL SITUATIONS

Reversal of Hartmann Procedure for Diverticulitis
Measures to identify and safely mobilize a dicult rectal stump have been described earlier. Other problems include a midrectal stric­ture or general rectal atrophy with narrowing, which can make safe passage of a circular stapler impossible. Sometimes the serial pas­sage of dilators per rectum remedies this problem, but rectal atro­phy demands a hand-sewn colorectal anastomosis. A rectal stricture requires resection to a healthy rectum. It may be tempting to pass the cartridge of the stapler without the anvil per rectum and to drive the trocar through either the stapled end of the rectum or the anterior wall below the staple line. However, if the divided end of rectum is brotic and thickened, too much is being asked of the stapling device, and tearing of the anastomosis will occur upon withdrawal. If the trocar is brought through the anterior rectum too close to the end, ischemia may develop between the anastomosis and the divided end of the rectum, with a risk of subsequent perforation.
A hand-sewn anastomosis is a safe technique. Another approach is a side of colon to end of rectum anastomosis, in which the sta­pler is passed through the opened end of the distal colon and opened through the antimesenteric wall, and then connected to the anvil that has been secured in the rectum with a purse string. 
Recurrent Rectal Cancer
Surgery for recurrent rectal cancer must have clear and realistic aims. If it is palliative, there must be a reasonable chance of improving qual­ity of life. Preoperative staging shows the pattern of recurrence in the pelvis and predicts the likelihood of success. Features suggesting that
ReopeRative pelvic SuRgeRy438
the recurrence is neither resectable nor curable include preoperative sciatic pain, lower limb lymphedema, bilateral ureteric obstruction, retroperitoneal paraaortic lymph node involvement by cancer, and especially xation of the pelvic mass to the side walls of the pelvis. Invasion of the sacrum suggests the need for a sacrectomy, and inva­sion of the prostate or bladder suggests the need for an exenteration. Here, the probability of cure and/or the quality of palliation must be balanced against the morbidity and mortality of the surgery.
With the advent of new biologic and chemotherapeutic agents, survival with stage IV colon and rectal cancer is prolonged, increas­ing the role of palliative surgery. Preoperative chemotherapy and radiation (if not already given) should be considered for bulky or advanced disease. Surgery is performed 8 to 10 weeks later.
Performing a repeat operation for recurrent rectal cancer is dif­cult. Pelvic brosis and scarring obliterate planes and hide land­marks, and ureteric stents may be impossible to pass, or impalpable if they are there. Dierentiating postoperative scarring and radiation eect from recurrent cancer may be dicult; sometimes a frozen section will be needed. Trial dissection of the presacral space may come to a halt when real or apparent fusion of a mid–sacral-level colorectal anastomosis—the site of recurrence xed to the sacrum— is encountered. In such cases, if a sense of partial fusion is obtained, the surgeon may choose to dissect posterior to Waldeyer fascia, which is a bold step, because shearing of the basivertebral veins from the sacrum may occur. However, the surgeon may be rewarded by nding a plane in which a brous layer of thickened membrane—or periosteum—is anterior to the sacrum. Bleeding may be dealt with by one of the methods described earlier. Although an anastomosis occa­sionally may be possible, usually distal transection and stapling of the lower rectum or abdominoperineal resection is required.
Situations previously regarded as absolute contraindications to resection, such as iliac vessel and ureteric involvement, have been challenged, with acceptable morbidity and long-term survival in spe­cialized referral centers. Likewise, extended sacropelvic resection, including even an occasional hemipelvectomy, can be performed at such centers to obtain high rates of clear margin and acceptable long­term disease-free survival. With these increasingly aggressive resec­tions, oen in irradiated elds, myocutaneous ap reconstruction, especially using the rectus muscle, can help decrease major perineal wound complications.
Intraoperative radiation therapy may improve local control of completely resected recurrent cancer by treating microscopic or macroscopically positive margins. e development of self-shielded portable machines (Mobetron, IntraOp Medical Corporation, Sunny­vale, Calif.) means that use may become more widespread. 
Redo Ileoanal Pelvic Pouch Procedure
e redo pelvic pouch procedure epitomizes the diculties encoun­tered in benign reoperative pelvic surgery. Not only has extensive pelvic dissection occurred with removal of the entire rectum, but a neorectum also has been placed into the pelvis, the blood supply of which is dependent on a single posterior blood vessel—the supe­rior mesenteric artery. e successful performance of this procedure emphasizes the principles previously discussed.
e results of a series of redo pelvic pouches at the Cleveland Clinic highlight some of the problems that can be encountered with such surgery, yet at the same time illustrate the success that can be achieved with experience and a well-organized approach to repeat operations in the pelvis.
From 1983–2007, 241 abdominal reconstructions of pelvic pouches were performed, with the most common indications being stula, leak, stricture, and pouch dysfunction. Ureteric stent placement was routine, and pouches were usually mobilized to the pelvic oor. Although the posterior pelvic mobilization was oen dicult and inadvertent pouch enterotomy was common, this was easily repaired.
In 71 cases a new pouch was constructed, and in 171 cases the original pouch was salvaged. Failure was observed in 29 cases with either pouch excision or proximal fecal diversion. Long-term pouch salvage was 85%, and compared with a matched nonrevised pouch group, only daytime leakage, nighttime leakage, and pad usage were signicantly higher. All other parameters and quality of life were similar between groups. 

SUMMARY

Reoperative pelvic surgery is oen complex and challenging, with the need for concomitant urologic, vascular, orthopedic, gynecologic, and reconstructive assistance. e keys to success are:
1. Careful preoperative planning, patient preparation, and in-
formed consent;
2. An ability to determine when the potential risks outweigh the
benets;
3. Knowing the limits of one’s expertise and the expertise of other
subspecialists who may be needed;
4. A methodical and careful operative approach with good help
and equipment;
5. Knowing when to turn back from the point of no return; and
6. An acceptance that extended resections and complex recon-
structions are probably best performed in a few highly special­ized centers with proven expertise and good outcomes.

S u g g e S t e d R e a d i n g

Austin KK, Solomon M. Pelvic exenteration with en bloc iliac vessel resection
for lateral pelvic wall involvement. Dis Colon Rectum. 2009;52(7):1223–
1233.
Colibaseanu DT, Dozois EJ, Mathis KL, etal. Extended sacropelvic resection
for locally recurrent rectal cancer: can it be done safely and with good
oncologic outcomes? Dis Colon Rectum. 2014;57(1):47–55. Heriot AG, Byrne CM, Lee P, etal. Extended radical resection: the choice
for locally recurrent rectal cancer. Dis Colon Rectum. 2008;51(3):284–291. Potter KC, Husband JE, Houghton SL, etal. Diagnostic accuracy of serial CT/
magnetic resonance imaging review vs. positron emission tomography/
CT in colorectal cancer patients with suspected and known recurrence.
Dis Colon Rectum. 2009;52(2):253–259. Mirnezami AH, Sagar PM, Kavanagh D, etal. Clinical algorithms for the sur-
gical management of locally recurrent rectal cancer. Dis Colon Rectum.
2010;53(9):1248–1257. Remzi FH, Fazio VW, Kirat HT, etal. Repeat pouch surgery by the abdomi-
nal approach safely salvages failed ileal pelvic pouch. Dis Colon Rectum.
2009;52(2):198–204.
N S
 C S
John L. Rombeau, Kimberly J. Hwa, and Dan Eisenberg


INTRODUCTION

Surgeons are justiably proud of their seminal contributions to nutri­tional care of the hospitalized patient. ese contributions include quantifying the prevalence of malnutrition, conrming the asso­ciation of malnutrition with adverse clinical outcomes, discovering parenteral nutrition (PN), and demonstrating, in selected groups of patients, that providing nutritional support (NS) may either prevent or correct malnutrition-associated morbidity. Despite the lack of conrmatory data in many surgical populations, surgeons must still decide when, what, and how to feed their patients while recognizing that the alternative is starvation.
In this chapter we review the assessment of nutritional status, indications for NS, dietary components and their delivery, and new directions in NS, with particular emphasis on colon and rectal sur­gery (CRS). For purposes of discussion, NS is dened arbitrarily as the provision of oral supplements, enteral feeding, or parenteral nutrients. Every attempt has been made to provide evidence-based recommendations. A complete discussion of this topic is beyond the scope of this short review. For more extensive information, the reader is referred to the Web site of the American Society for Parenteral and Enteral Nutrition (ASPEN) at http://www.nutritioncare.org/. 

NUTRITIONAL ASSESSMENT

e decision to provide NS is based, in part, on measurement of cri­teria predictive of a malnutrition-induced adverse outcome. It should be emphasized that these measures are not totally determined by the patient’s nutritional status; they are also inuenced by the pri­mary diagnosis, degree of metabolic stress, and presence of infec­tion. Extensive information is available on nutritional assessment for perioperative NS, ranging from sophisticated multivariate indi­ces (which are more feasible with dedicated teams performing these functions) to more readily performed clinical history and measure­ment of serum proteins. Important assessment criteria to initiate NS are shown in Box 83-1.
It should be noted that these criteria are guidelines and not abso­lute recommendations for NS. Clinical judgment remains the most important determinant in deciding when, what, and how to feed patients. 
loss and reduced serum proteins. Signicant loss of body weight is perhaps the most important single indication for NS. Nonvolitional loss of more than 10% of usual weight within 3 months prior to sur­gery and/or a serum albumin level less than 3 g/dL in the euvolemic state are important criteria to initiate some type of perioperative NS (Box 83-1).
Severe Malnutrition
e indications for NS, particularly for parenteral feeding, have become more limited during the past 40 years because of the lack of conrmatory data in the most common groups of minimally and moderately malnourished patients.
Severe malnutrition in perioperative patients is associated with adverse postoperative outcomes, including increased infection, poor wound healing, anastomotic breakdown, coagulopathy, and heart fail­ure. Delaying an elective colorectal operation to improve the patient’s nutritional status may therefore be benecial, but only if the patient is severely malnourished. e decision to use NS preoperatively must be made with an appreciation of the rising costs of health care, issues with third-party payor reimbursement, and administrative pressures to decrease hospital stay. In a recent Cochrane Review of preopera­tive nutrition in patients undergoing digestive tract surgery, it was concluded that immune-enhancing nutrition and PN had signicant outcome benets; however, trials evaluating standard enteral or oral supplemental nutrition were inconclusive.
One of the goals of preoperative nutrition in this patient popula­tion is to minimize loss of nitrogen from skeletal muscle by decreas­ing the duration of fasting and supporting muscle mass and immune function. Despite these metabolic goals, data only support aggres­sive NS for the most severely malnourished surgical patients because neither preoperative PN nor enteral nutrition (EN) provides a clear benet in either the borderline or mildly malnourished patient. Moreover, multiple studies that failed to show a clear benet, and that occasionally showed a detriment in these patients, led ASPEN to conclude that perioperative NS in patients with cancer should be limited to persons with severe malnutrition who are likely to be unable to eat for more than 7 to 10 days aer surgery, as shown in
Box 83-1. PN should be given to patients who will not be able to meet
their nutritional requirements by oral or enteral tube feeds within the same period. 

INDICATIONS FOR NUTRITIONAL SUPPORT

General Indications
General indications for perioperative NS for the patient undergoing CRS include severe malnutrition as determined clinically by weight
Postoperative Nutrition
With the exception of the severely malnourished preoperative patient, most NS is provided postoperatively. e traditional postoperative management of keeping patients “nil by mouth” (NPO) until clinical signs of return of bowel function are present is no longer justied. To our knowledge, there is no signicant outcome benet with starting a clear liquid diet versus a regular or low-residue diet. However, initiat­ing a regular diet oers numerous nutritional advantages, including
439
NutritioNal Support iN ColoreCtal Surgery440
BOX 83-1: Strong and Moderate Indications for
Perioperative Nutritional Support
Strong Indications
ONE of the following:  • Nonvolitionallossof≥10% usual body weight within 2-3 mo
prior to hospitalization
 • Serumalbumin<3.0g/dLineuvolemicstate 
Moderate Indications
TWO of the following:
 • Currentoralintakemeeting<50%oftotalenergyneeds  • Starvation>7days  • Anticipationofnutritionalsupport>7days  • Serumprealbumin<150mg/dLineuvolemicstate
increased caloric intake, decreased protein catabolism and weight loss, improved patient satisfaction, and decreased length of hospital stay. Moreover, level 1 evidence supports early postoperative feeding in patients undergoing elective colon and rectal surgery. Initiation of enteral feeds within 2 days of surgery shortens postoperative ileus and enhances return to oral intake. us, it behooves the colorectal surgeon to anticipate these issues and plan appropriately; for example, intraoperative placement of feeding tubes may be warranted to allow for early EN in the malnourished patient with colorectal cancer. PN should be reserved for patients who cannot meet their nutrient needs by 7 days aer surgery. Fast-track or enhanced recovery programs begin oral intake within 24 hours of surgery (see the Early Postopera-
tive Feeding: “Fast Track” section). Early administration of an oral
diet diminishes the duration of a postoperative ileus, decreases post­operative complication rates, and lowers mortality. No signicant increase in anastomotic leaks or dehiscence occurs, and early feeding results in a trend toward lower infection rates and decreased length of hospital stays. e major complication related to the early initiation of a diet is an increased risk of vomiting and bloating. 
Specific CRS Indications
Inflammatory Bowel Disease
Almost all patients with Crohn disease and approximately one third of those with ulcerative colitis will require surgery. Some degree of mal­nutrition is common among most perioperative patients with inam­matory bowel disease (IBD) because of insucient dietary intake, malabsorption, chronic inammation, and adverse eects of medica­tions. e extent of malnutrition depends on the chronicity of the dis­ease, its severity, and the degree of involvement of the small intestine.
Preoperative malnutrition, as dened by unintended weight loss, or decreased serum proteins such as albumin and prealbumin, is associated with increased postoperative morbidity in persons with IBD. In fact, a preoperative serum albumin level less than 3.5 g/dL was associated with an increased risk of anastomotic leak aer colon resection. us aggressive preoperative and postoperative NS has been recommended for selected surgical patients with IBD.
Insucient data exist to support either a specic perioperative feeding regimen or generalized goals of nutritional care for patients with IBD.
Some patients with Crohn disease have undergone multiple resec­tions of both the small and large intestine, leading to short bowel syndrome. Nutritional management of these patients is particularly challenging. is topic is described elsewhere in this book (Chapter 72). 
Colorectal Cancer
As in the cohort with IBD, preoperative malnutrition is present in some patients with colorectal cancer. Cancer stage, type, location
and size, and prior neoadjuvant treatment with chemotherapy and/ or radiation all contribute to decreased nutrient intake. In addition, the presence of a wasting syndrome, or cancer cachexia, may lead to severe malnutrition of the patient with colorectal cancer. Mal­nutrition and severe weight loss negatively aect surgical outcomes of patients with cancer. In this context, evidence suggests that early feeding aer surgery is not only safe but is associated with decreased postoperative morbidity and mortality.
Conrmatory data are lacking to support the use of specic dietary formulas or the precise timing for initiating NS. In a study of 963 patients undergoing surgery for colorectal cancer, Gustasson and colleagues found that closer adherence to an enhanced recovery protocol resulted in fewer than 25% postoperative complications and a shorter length of hospital stay when compared with a nonprotocol group. eir protocol included a high-calorie liquid intake up to 2 hours before surgery (sometimes prohibited by anesthesiologists in the United States; see the New Directions section) and oral feeding as early as 4 hours aer surgery. 

ESTIMATION OF NUTRIENT REQUIREMENTS

Perioperative nutrient needs have been measured in major clinical settings ranging from elective surgery to the severely stressed, criti­cally ill patient. Knowledge of caloric and protein requirements is particularly relevant to the patient undergoing CRS. Consultation with a clinical dietician is frequently helpful to determine nutrient requirements, particularly in settings in which the surgeon is less experienced with these calculations.
Calories
Glucose is the preferred energy source, particularly for NS. When provided in sucient amounts, glucose reduces protein breakdown and nitrogen losses by suppressing hepatic gluconeogenesis and lim­iting the need for amino acids to be oxidized for energy.
Lipid is another important exogenous source of energy. It also spares nitrogen and is oen given as a supplement to PN-based carbohydrate in conditions of dicult regulation of serum glucose levels. With the recognition that nutrition is a requisite component of complete perioperative care, most patients initially should be pre­scribed 25 kcal/kg of actual body weight to be increased gradually to 30 to 35 kcal/kg if weight gain is desired. 
Protein
Protein is a mandatory component of NS. It is composed of approx­imately one-sixth nitrogen. Grams of protein can be converted to grams of nitrogen by dividing by 6.25. is is oen confusing to surgeons, inasmuch as protein loss is usually expressed as grams of nitrogen and protein intake is generally calculated as grams of protein per kilogram of body weight. Based on extensive metabolic studies in surgical patients, we prescribe approximately 1.5 g of protein/kg actual body weight/day. Nitrogen losses are monitored every few days through nitrogen balance by measuring 24-hour urinary urea nitrogen with an addition of 4 g as an estimate of fecal and integumentary losses. Positive nitrogen balance corre­lates with an anabolic state, whereas a negative balance suggests catabolism.
Estimates of total caloric and protein needs are also based, in part, on the patient’s body mass index (body weight kg/height cm), listed in Table 83-1. e caloric ratio of protein:fat:glucose should approxi- mate 20%:30%:50%. Lipids are delivered separately with PN and are limited to 20% to 30% of the nonprotein calories as a result of their tendency for oxidation and free radical formation.